American Vanguard (NYSE:AVD) Director Purchases $67,500.00 in Stock

American Vanguard Corporation (NYSE:AVDGet Free Report) Director Patrick Gottschalk purchased 25,000 shares of American Vanguard stock in a transaction on Tuesday, May 19th. The stock was bought at an average price of $2.70 per share, with a total value of $67,500.00. Following the transaction, the director owned 191,705 shares of the company’s stock, valued at approximately $517,603.50. This represents a 15.00% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

American Vanguard Price Performance

Shares of NYSE:AVD traded down $0.04 during trading on Tuesday, hitting $2.67. 159,627 shares of the company’s stock were exchanged, compared to its average volume of 203,420. The company has a debt-to-equity ratio of 1.39, a current ratio of 2.32 and a quick ratio of 1.41. American Vanguard Corporation has a 52-week low of $2.05 and a 52-week high of $5.92. The business’s 50-day simple moving average is $2.85 and its 200 day simple moving average is $3.95. The company has a market cap of $76.30 million, a price-to-earnings ratio of -1.68 and a beta of 1.48.

American Vanguard (NYSE:AVDGet Free Report) last released its quarterly earnings results on Wednesday, May 6th. The basic materials company reported ($0.14) earnings per share for the quarter, missing the consensus estimate of ($0.06) by ($0.08). The firm had revenue of $123.57 million for the quarter, compared to analysts’ expectations of $120.00 million. American Vanguard had a negative net margin of 8.71% and a negative return on equity of 4.13%.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings raised shares of American Vanguard from a “sell (e+)” rating to a “sell (d-)” rating in a report on Monday, May 4th. One research analyst has rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $12.00.

Get Our Latest Research Report on AVD

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently modified their holdings of the company. Potomac Capital Management Inc. purchased a new position in American Vanguard in the fourth quarter valued at $1,751,000. Essex Investment Management Co. LLC purchased a new position in American Vanguard in the third quarter valued at $2,136,000. Russell Investments Group Ltd. boosted its holdings in American Vanguard by 1,397.5% in the fourth quarter. Russell Investments Group Ltd. now owns 336,277 shares of the basic materials company’s stock valued at $1,285,000 after purchasing an additional 313,821 shares during the period. EVR Research LP raised its stake in American Vanguard by 82.0% in the fourth quarter. EVR Research LP now owns 618,657 shares of the basic materials company’s stock valued at $2,363,000 after buying an additional 278,657 shares in the last quarter. Finally, Curi Capital LLC lifted its holdings in American Vanguard by 1,285.5% during the 2nd quarter. Curi Capital LLC now owns 289,573 shares of the basic materials company’s stock worth $1,135,000 after buying an additional 268,673 shares during the last quarter. 79.00% of the stock is currently owned by hedge funds and other institutional investors.

About American Vanguard

(Get Free Report)

American Vanguard Corporation (NYSE: AVD) is a developer, manufacturer and marketer of specialty chemical products for crop protection, turf and ornamental care, and public health pest control. Headquartered in Newport Beach, California, the company offers a portfolio of insecticides, herbicides, fungicides and rodenticides designed for use across agricultural, turf and urban pest management applications. Its research and development efforts focus on novel chemistries and formulation technologies that address emerging pest resistance and regulatory requirements.

The company’s product lines include emulsifiable concentrates, wettable powders, granular formulations, baits and liquid concentrates sold under proprietary brand names.

Featured Stories

Receive News & Ratings for American Vanguard Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Vanguard and related companies with MarketBeat.com's FREE daily email newsletter.